ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
TradingHault
|
87 |
31K |
0 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
87
|
31K
|
0
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Updated Uranium Grades achieve up to 7139ppm U308 in SWC
|
|
TradingHault
|
46 |
14K |
1 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
46
|
14K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
TradingHault
|
87 |
31K |
0 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
87
|
31K
|
0
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Updated Uranium Grades achieve up to 7139ppm U308 in SWC
|
|
TradingHault
|
46 |
14K |
3 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
46
|
14K
|
3
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Updated Uranium Grades achieve up to 7139ppm U308 in SWC
|
|
TradingHault
|
46 |
14K |
0 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
46
|
14K
|
0
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Updated Uranium Grades achieve up to 7139ppm U308 in SWC
|
|
TradingHault
|
46 |
14K |
3 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
46
|
14K
|
3
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Uranium Grades exceeding 4245ppm U3O8 in SWC trench assays
|
|
TradingHault
|
25 |
9.4K |
3 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
25
|
9.4K
|
3
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Uranium Grades exceeding 4245ppm U3O8 in SWC trench assays
|
|
TradingHault
|
25 |
9.4K |
2 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
25
|
9.4K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Updated Uranium Grades achieve up to 7139ppm U308 in SWC
|
|
TradingHault
|
46 |
14K |
2 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
46
|
14K
|
2
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Updated Uranium Grades achieve up to 7139ppm U308 in SWC
|
|
TradingHault
|
46 |
14K |
3 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
46
|
14K
|
3
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Becoming a substantial holder MB
|
|
TradingHault
|
10 |
4.4K |
2 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
10
|
4.4K
|
2
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Becoming a substantial holder MB
|
|
TradingHault
|
10 |
4.4K |
1 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
10
|
4.4K
|
1
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Becoming a substantial holder MB
|
|
TradingHault
|
10 |
4.4K |
3 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
10
|
4.4K
|
3
|
|
ASX - By Stock
|
MTM |
Re:
MTM - Niobium Grades of up to 36% at recently acquired project
|
|
TradingHault
|
292 |
82K |
1 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
292
|
82K
|
1
|
|
ASX - By Stock
|
CUS |
Re:
Ann: Geophysical Survey Update - Peake Project
|
|
TradingHault
|
8 |
3.5K |
1 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
8
|
3.5K
|
1
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Becoming a substantial holder MB
|
|
TradingHault
|
10 |
4.4K |
1 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
10
|
4.4K
|
1
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading January 4
|
|
TradingHault
|
202 |
31K |
0 |
04/01/24 |
04/01/24 |
ASX - Day Trading
|
202
|
31K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
4 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
64
|
22K
|
4
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
1 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
1 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Becoming a substantial holder MB
|
|
TradingHault
|
10 |
4.4K |
5 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
10
|
4.4K
|
5
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Uranium Grades exceeding 4245ppm U3O8 in SWC trench assays
|
|
TradingHault
|
25 |
9.4K |
1 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
25
|
9.4K
|
1
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Uranium Grades exceeding 4245ppm U3O8 in SWC trench assays
|
|
TradingHault
|
25 |
9.4K |
1 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
25
|
9.4K
|
1
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Uranium Grades exceeding 4245ppm U3O8 in SWC trench assays
|
|
TradingHault
|
25 |
9.4K |
3 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
25
|
9.4K
|
3
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Uranium Grades exceeding 4245ppm U3O8 in SWC trench assays
|
|
TradingHault
|
25 |
9.4K |
2 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
25
|
9.4K
|
2
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Uranium Grades exceeding 4245ppm U3O8 in SWC trench assays
|
|
TradingHault
|
25 |
9.4K |
0 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
25
|
9.4K
|
0
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Uranium Grades exceeding 4245ppm U3O8 in SWC trench assays
|
|
TradingHault
|
25 |
9.4K |
3 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
25
|
9.4K
|
3
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
1 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Ground radiometric survey defines extensive uranium zones
|
|
TradingHault
|
16 |
6.1K |
1 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
16
|
6.1K
|
1
|
|
ASX - By Stock
|
CXO |
Re:
Ann: Strategic Review of Operations Underway
|
|
TradingHault
|
318 |
146K |
3 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
318
|
146K
|
3
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Ground radiometric survey defines extensive uranium zones
|
|
TradingHault
|
16 |
6.1K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
16
|
6.1K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Ground radiometric survey defines extensive uranium zones
|
|
TradingHault
|
16 |
6.1K |
2 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
16
|
6.1K
|
2
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Ground radiometric survey defines extensive uranium zones
|
|
TradingHault
|
16 |
6.1K |
1 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
16
|
6.1K
|
1
|
|
ASX - By Stock
|
GLA |
Re:
Ann: Ground radiometric survey defines extensive uranium zones
|
|
TradingHault
|
16 |
6.1K |
1 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
16
|
6.1K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
CUS |
Re:
Ann: Change of Director's Interest - A Belperio
|
|
TradingHault
|
5 |
1.8K |
1 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
5
|
1.8K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
1 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
0 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
1 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
1 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Stroke Clinical Trial Update
|
|
TradingHault
|
64 |
22K |
1 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
64
|
22K
|
1
|
|